Please find enclosed the Trading Plans dated August 05, 2026 received from Designated Persons of the company and same have been approved by the compliance officer.

~)] nephroplus Ref: NEPHROPLUS/SE/067 August 5, 2026 To To BSE Limited Na(cid:415)onal Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Lis(cid:415)ng Centre Through: NEAPS Sub: In(cid:415)ma(cid:415)on of Trading Plan under Regula(cid:415)on 5(5) of SEBI (Prohibi(cid:415)on of Insider Trading) Regula(cid:415)ons, 2015 ("SEBI PIT Regula(cid:415)ons") Dear Sir/Madam, Pursuant to Regula(cid:415)on 5(5) of SEBI PIT Regula(cid:415)ons read with the Company’s Code of Conduct for Regula(cid:415)ng, Monitoring and Repor(cid:415)ng Trading by Designated Persons and Their Immediate Rela(cid:415)ves in the Securi(cid:415)es of the Company; and Code of Prac(cid:415)ces and Procedures for Fair Disclosure of Unpublished Price Sensi(cid:415)ve Informa(cid:415)on (“Code of Conduct”), please find enclosed Trading Plans dated August 5, 2026, received from Mr. Rohit Singh, Group Chief Execu(cid:415)ve Officer & Designated Person and Mr. Sukaran Singh Saluja, CEO - India and Nepal Business & Designated Person as per the Code of Conduct. The enclosed Trading Plans have been approved in accordance with the applicable provisions of SEBI PIT Regula(cid:415)ons and Code of Conduct today, i.e., Wednesday, August 5, 2026. You are requested to take the above informa(cid:415)on on record. Yours faithfully, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895 Encl: a/a Nephrocare Health Services limited (Global Corporate Headquarters) (For merly Nephrocare Health Services Private Limited) 5'" Floor, D Block, 1Labs Centre. Plot. 18, Software Units Layout, Survey No 64, Madhapur, Hyderabad • 500 081, Telangana, Indra. ~ +91 40 4240 8039 0 contactus@nephroplus com 9 www nephroplus com CIN: L85100TG2009PLC066359 J GSTIN: 36AADCN1504A1Z8 J ISD GST: 36AADCN1504A2Z7 The Compliance Officer Nephrocare Health Services Limited 5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad 500 081, Telangana, India Subject: Trading plan Ref: As per the provisions of Regulation 5(5) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ("SEBI PIT Regulations") read with the Company's Code of Conduct for Regulating, Monitoring and Reporting Trading by Designated Persons an~ Their Immediate Relatives in the Securities of the Company; and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ("Code of Conduct"). I, Roh it Singh, Group Chief Executive Officer and one of the Designated Person under th_e Code of Conduct, hereby submit the following trading plan for your approval: Value of vatlete be- N~ef Pdee limit nance Sr.No. ~{No.of transadiertW Tl'ai:11119 Days/'Jterlod Rs.* Securities to be tm,ded -'Purch.-~~~ - Monday, December 7,Minimum Rs. 1 30,000 Equity Shares Sale 2026 to Friday, 700.00 per Equity December 11, 2026 Share *The price limit range has been derived between the closing price on the day before submission of Trading Plan and up to 20% lower than such closing price. Closing Price on August 04, 2026 on National Stock Exchange of India Ltd. was Rs. 713.15. I hereby undertake and confirm that: a. I/my immediate relatit.•e(s) will not trade in the securities Nephrocare Health Services Limited during the cool-off period of 120 calendar days as prescribed under Regulation 5(2)(i) of the SEBI (Prohibition of Insider Trading) Regulation, 2015. b. I/my iffimeeliate relati•,e(s) will not trade in the securities of Nephrocare Health Services Limited for market abuse. c. This Trading Plan, once approved, shall be irrevocable and I will mandatorily implement the trades contempl.it~d in thi~ Truding rlan and will not deviate this Tradi11g Plan or execute a11y trade in the securities of Nephrocare Health Services Limited outside the scope of this Trading Plan except as provided in the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. d. I will execute the trade(s) as per the Trading Plan, only if the execution price is within the limits set out in the table above for the trade and I will not execute the trade if the price of the equity shares is outside the limit set out in the table. e. I shall not implement the Trading Plan, if the unpublished price sensitive information, if any, in myfGldf possession at the time of formulation of this plan has not become generally available at the time of the commencement of implementation of the Trading Plan. f. I am fully aware of and understand, my obligations under the Code of Conduct for Regulating, Monitoring and Reporting of trades of Designated Persons and immediate relatives of Designated Persons; and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by Nephrocare Health Services Limited and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and will comply with such obligations at all,times. • Signaturet L, Name: Rohit Singh Designation: Group Chief Executive Officer Employee Code: NP7676 Place: ~'1~--.J Date: 0 ~ . 0 g . 'lO'l-, For office use only The above Trading Plan is Approved/~e1ected, In case of Rejection, the reasons of rejection are as follows: NA For Nephrocare Health Services • (Formerly Nephrocare Health Se ited) Kishore Kathri Company Secretary & Compliance Officer ICSI M. No. F9895 Date: l · 0 S' • t) '½l-b The Compliance Officer Nephrocare Health Services Limited 5 Floor, D Block, ilabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad 500 081, Telangana, India Subject: Trading plan Ref: As per the provisions of Regulation 5(5) of SEBI (Prohibition of Insider T d' ) · {" ra mg R I 20 egu at~ons, 1_s _SEBI PIT Regulations") read with the Company's Code of Conduct for Regulating, Monitoring and Reporting Trading by Designated Persons and Their lmmed· ·t · • h . . ,a e Re I at1ves m t e Securities of the Company; and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ("Code of Conduct"). I, Sukaran Singh Saluja, CEO - India and Nepal Business and one of the Designated Person under the Code of Conduct, hereby submit the following trading plan for your approval: Monday, December 7, Minimum Rs. 1 60,000 Equity Shares Sale 2026 to Friday, 00.00 per Equit December 11, 2026 hare *The price limit range has been derived between the closing price on the day before submission of Trading Plan and up to 20% lower than such closing price. Closing Price on August 04, 2026 on National Stock Exchange_of India Ltd. was Rs. 713.15. I hereby undertake and confirm that: a. I/my immeeliate relative(s) will not trade in the securities Nephrocare Health Services Limited during the cool-off period of 120 calendar days as prescribed under Regulation 5(2)(i) of the SEBI (Prohibition of Insider Trading) Regulation, 2015. b. I/my immeaiate relati>.•e(s) will not trade in the securities of Nephrocare Health Services Limited for market abuse. c. This Trading Plan, once approved, shall be irrevocable and I will mandatorily implement the trades contemplated in this Trading Plan and will not deviate this Trading Plan or ex~cute ~ny trade in the securities of Nephrocare Health Services Limited outside the scope of this Tra~mg Plan except as provided in the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. d. will execute the trade(s) as per the Trading Plan, only if the execution pric~ is withi_n the limits set out in the table above for the trade and I will not execute the trade rf the prrce of the equity shares is outside the limit set out In the ldule. Scanned with OKEN Scanner e. s~all not implement the Trading Plan, if the unpublished price sensitive information, if an [Showing first 8,000 characters — download PDF for full document]